News for Healthier Living

CRISPR Screening Reveals H2AZ1 as a Key Driver of Mesenchymal Stem Cell Aging

In a new discovery that may reshape anti-aging strategies, researchers have identified the histone variant H2A.Z variant histone 1 (H2AZ1) as a pivotal driver of cellular aging in human mesenchymal stem cells (hMSCs). By leveraging CRISPR-based genomic screening, the research team found that depletion of H2AZ1 can reverse cellular aging hallmarks and rejuvenate stem cell function. Conversely, its overexpression accelerates the aging process. The study unveils a novel epigenetic mechanism: H2AZ1 silences the secreted growth factor pleiotrophin (PTN), which is critical for tissue repair and hippocampal neurogenesis, by binding to its five enhancer regions (E1-E5), offering a new therapeutic target to delay aging and enhance regenerative medicine.

June 17, 2025


June 27 2025

June 26 2025

June 25 2025

June 24 2025

June 23 2025

June 22 2025

June 21 2025

June 20 2025

June 19 2025

June 18 2025

June 17 2025

June 16 2025

June 15 2025

June 14 2025

June 13 2025